Skip to Content


Buy Olanzapine (Zyprexa) online

How and where to order Zyprexa (Olanzapine) 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tablets online:

Shop:DFH PHARMACY - 10% discount coupon DFH10
Sellers:OLANZAPINE STORES
Prices:from $0.27 per pill
Forms:2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tablets
Quantity:30-360 pills
Type:Olanzapine brand, Zyprexa generic
Payment:Visa, Mastercard, AmEx, Bitcoin
Delivery:Regular and express mail service
Shipping:Worldwide, including USA, UK, Europe, Canada, Australia


Indications and usage:

Zyprexa (Olanzapine) tablets are indicated for:

  • the treatment of schizophrenia in adults and adolescents
  • manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder in adults and adolescents
  • adjunct to valproate or lithium in the treatment of manic or mixed episodes associated with bipolar I disorder
  • psychotic disorders
  • suicidal thinking and behaviors
  • borderline personality disorder
  • obsessive compulsive disorder
  • paranoid disorder
  • eating disorders like anorexia and anorexia nervosa
  • generalized anxiety disorder
  • panic disorder
  • delusional parasitosis
  • post-traumatic stress disorder
  • Tourette syndrome
  • stuttering
  • agitation and agitated state
  • Asperger's syndrome
  • body dysmorphic disorder
  • insomnia and sleep disorders
  • nausea and vomiting induced by chemotherapy
  • with fluoxetine to treat certain types of depression such as major depressive disorder, resistant depression, depressive episodes associated with bipolar I disorder

    Zyprexa (Olanzapine) intramuscular injections are prescribed for the therapy of acute agitation associated with schizophrenia and bipolar I mania.


    Dosage and administration:

  • Take Olanzapine (Zyprexa) exactly as prescribed. Your healthcare provider may need to change (adjust) the dose of this medication until it is right for you.
  • If you miss a dose of Zyprexa, take the missed dose as soon as you remember. If it is almost time for the next dose, just skip the missed dose and take your next dose at the regular time. Do not take two doses of this medicine at the same time.
  • To prevent serious side effects, do not stop taking olanzapine suddenly. If you need to stop taking Zyprexa, your doctor can tell you how to safely stop taking it.
  • If you take too much this drug, call your doctor or poison control center right away, or get emergency treatment.
  • Zyprexa (Olanzapine) can be taken with or without food.
  • This medication is usually taken one time each day.
  • Take Zyprexa Zydis as follows:

    - be sure that your hands are dry.
    - open the sachet and peel back the foil on the blister. Do not push the tablet through the foil.
    - As soon as you open the blister, remove the tablet and put it into your mouth.
    - The tablet will disintegrate quickly in your saliva so that you can easily swallow it with or without drinking liquid.
  • Call your healthcare provider if you do not think you are getting better or have any concerns about your condition while taking Olanzapine (Zyprexa) tablets.


    Overdosage:

    Human experience

    In postmarketing reports of overdose with olanzapine alone, symptoms have been reported in the majority of cases. In symptomatic patients, symptoms with >= 10% incidence included agitation/aggressiveness, dysarthria, tachycardia, various extrapyramidal symptoms, and reduced level of consciousness ranging from sedation to coma. Among less commonly reported symptoms were the following potentially medically serious reactions: aspiration, cardiopulmonary arrest, cardiac arrhythmias (such as supraventricular tachycardia and 1 patient experiencing sinus pause with spontaneous resumption of normal rhythm), delirium, possible neuroleptic malignant syndrome, respiratory depression/arrest, convulsion, hypertension, and hypotension.

    Management of overdose

    There is no specific antidote to an overdose of Zyprexa pills. The possibility of multiple drug involvement should be considered. Establish and maintain an airway and ensure adequate oxygenation and ventilation. Cardiovascular monitoring should commence immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias.

    Contact a certified poison control center for the most up to date information on the management of overdosage.


    Dosage forms and strengths:

  • Zyprexa (Olanzapine) tablets not scored: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg.
  • Zyprexa Zydis (Olanzapine) not scored orally disintegrating tablets: 5 mg, 10 mg, 15 mg, 20 mg.
  • Zyprexa (Olanzapine) intramuscular injection: 10 mg single-dose vial.


    Contraindications:

  • None with Zyprexa monotherapy.
  • When using olanzapine and fluoxetine in combination, also refer to the contraindications section of the package insert for Symbyax.
  • When using Zyprexa (Olanzapine) in combination with lithium or valproate, refer to the contraindications section of the package inserts for those products.


    Warnings and precautions:

  • Elderly patients with dementia-related psychosis: increased risk of death and increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack).
  • Suicide: the paradoxical possibility of a suicide attempt is inherent in schizophrenia and in bipolar I disorder, and close supervision of high-risk patients should accompany drug therapy; when using in combination with fluoxetine.
  • Neuroleptic malignant syndrome: manage with immediate discontinuation and close monitoring.
  • Drug reaction with eosinophilia and systemic symptoms (DRESS): Discontinue if DRESS is suspected.
  • Metabolic changes: atypical antipsychotic drugs have been associated with metabolic changes including hyperglycemia, dyslipidemia, and weight gain.
  • Hyperglycemia and diabetes mellitus: in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients taking olanzapine.
  • Patients taking olanzapine should be monitored for symptoms of hyperglycemia and undergo fasting blood glucose testing at the beginning of, and periodically during, treatment.
  • Dyslipidemia: undesirable alterations in lipids have been observed. Appropriate clinical monitoring is recommended, including fasting blood lipid testing at the beginning of, and periodically during, treatment.
  • Weight gain: potential consequences of weight gain should be considered. Patients should receive regular monitoring of weight.
  • Tardive dyskinesia: discontinue if clinically appropriate.
  • Orthostatic hypotension: orthostatic hypotension associated with dizziness, tachycardia, bradycardia and, in some patients, syncope, may occur especially during initial dose titration. Use caution in patients with cardiovascular disease, cerebrovascular disease, and those conditions that could affect hemodynamic responses.
  • Leukopenia, neutropenia, and agranulocytosis: has been reported with antipsychotics, including Zyprexa (Olanzapine).
  • Seizures: use cautiously in patients with a history of seizures or with conditions that potentially lower the seizure threshold.
  • Potential for cognitive and motor impairment: has potential to impair judgment, thinking, and motor skills. Use caution when operating machinery.
  • Anticholinergic (antimuscarinic) effects: use with caution with other anticholinergic drugs and in patients with urinary retention, prostatic hypertrophy, constipation, paralytic ileus or related conditions.
  • Hyperprolactinemia: may elevate prolactin levels.
  • Use in combination with fluoxetine, lithium or valproate: also refer to the package inserts for Symbyax, lithium, or valproate.
  • Laboratory tests: monitor fasting blood glucose and lipid profiles at the beginning of, and periodically during, treatment.


    Adverse reactions, side effects:

    Most common adverse reactions (>=5% and at least twice that for placebo) associated with olanzapine therapy were abdominal pain, akathisia, amnesia, asthenia, back pain, constipation, dizziness, dry mouth, fatigue, headache, increased appetite, increased salivation, pain in extremity, paresthesia, personality disorder, postural hypotension, sedation, somnolence, speech disorder, tremor, weight gain, weight increased.

    To report suspected side effects of Zyprexa (Olanzapine) tablets contact Eli Lilly pharmaceutical company or your local FDA.


    Drug interactions:

  • Diazepam: may potentiate orthostatic hypotension.
  • Alcohol: may potentiate orthostatic hypotension.
  • Carbamazepine: increased clearance of olanzapine.
  • Fluvoxamine: may increase olanzapine levels.
  • Zyprexa and fluoxetine in combination: Also refer to the drug interactions section of the package insert for Symbyax.
  • CNS acting drugs: caution should be used when taken in combination with other centrally acting drugs and alcohol.
  • Antihypertensive agents: enhanced antihypertensive effect.
  • Levodopa and dopamine agonists: may antagonize levodopa/dopamine agonists.
  • Lorazepam (IM): increased somnolence with im olanzapine.
  • Other concomitant drug therapy: when using Olanzapine (Zyprexa) in combination with lithium or valproate, refer to the drug interactions sections of the package insert for those products.

    Related medications:

  • Fluoxetine tablets
  • Lithium Carbonate (Eskalith)


    Use in specific populations:

    Pregnancy

    May cause extrapyramidal and/or withdrawal symptoms in neonates with third trimester exposure.

    Lactation

    Olanzapine is present in human milk. There are reports of excess sedation, irritability, poor feeding and extrapyramidal symptoms (tremors and abnormal muscle movements) in infants exposed to olanzapine through breast milk. There is no information on the effects of olanzapine on milk production.

    Infertility

    Based on the pharmacologic action of olanzapine (D2 receptor antagonism), treatment with Zyprexa may result in an increase in serum prolactin levels, which may lead to a reversible reduction in fertility in females of reproductive potential.

    Pediatric use

    Safety and effectiveness of Zyprexa in children < 13 years of age have not been established. Safety and effectiveness of Zyprexa and fluoxetine in combination in children < 10 years of age have not been established.


    Drug abuse and dependence:

    Dependence

    In studies prospectively designed to assess abuse and dependence potential, olanzapine was shown to have acute depressive CNS effects but little or no potential of abuse or physical dependence in rats administered oral doses up to 15 times the daily oral MRHD (20 mg) and rhesus monkeys administered oral doses up to 8 times the daily oral MRHD based on mg/m2 body surface area.

    Olanzapine has not been systematically studied in humans for its potential for abuse, tolerance, or physical dependence. While the clinical trials did not reveal any tendency for any drug-seeking behavior, these observations were not systematic, and it is not possible to predict on the basis of this limited experience the extent to which a CNS-active drug will be misused, diverted, and/or abused once marketed. Consequently, patients should be evaluated carefully for a history of drug abuse, and such patients should be observed closely for signs of misuse or abuse of olanzapine (e.g., development of tolerance, increases in dose, drug-seeking behavior).


    Where to buy olanzapine online:

    To purchase Zyprexa (Olanzapine) 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.


    Here is a list of popular medications containing olanzapine as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
    Oleanz
  • Tablets; Oral; Olanzapine 2.5 mg, 5 mg, 7.5 mg, 10 mg
  • Sun Pharmaceutical Industries
  • Genome Pharmaceuticals
  • Maver Laboratorios
  • Pharmaplan
  • Zyprexa
  • Granules for Suspension; Oral; Olanzapine 10 mg / g
  • Injectable; Injection; Olanzapine 10 mg
  • Tablets, Film-Coated; Oral; Olanzapine 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg
  • Eli Lilly
  • Zyprexa Zydis
  • Tablets, Orally Disintegrating; Oral; Olanzapine 5 mg, 10 mg, 15 mg, 20 mg
  • Wafer; Oral; Olanzapine 5 mg, 10 mg, 15 mg 20 mg
  • Eli Lilly